Company
HALIX
- Biotech
- Headquarters:
- Leiden Bio Science Park, Netherlands
- Offices:
- Leiden, Netherlands
- Parent:
- HAL Allergy Holding B
Description
HALIX develops and GMP-manufactures biologics, including viral vectors and recombinant proteins, using mammalian expression systems, upstream processing, filtration, chromatography, aseptic filling, and lyophilization for clinical and commercial production.
HALIX is located in the Netherlands ecosystem.
Related
NorthX BiologicsNorthX Biologics provides custom-fit biologics development and GMP manufacturing services, delivering process development, analytics,…
Vioti PharmaceuticalsVioti Pharmaceuticals provides end-to-end CDMO development and manufacturing services for animal health biologic drug substances and drug…
IBA LifesciencesIBA Lifesciences develops research tools based on Strep-tag® technology for protein and cell isolation, providing purification and analysis…
Oxford BiomedicaOxford Biomedica provides end-to-end CDMO services for cell and gene therapy clients, using lentivirus, AAV, and other viral vectors to…
APCAPC provides process development services and technology platforms that accelerate pharmaceutical and biologics development for pharma and…
NTrans TechnologiesNTrans Technologies develops a non-viral delivery platform for cell and gene therapies, providing modular delivery solutions for…
BIMINI BiotechBIMINI Biotech develops first-in-class small-molecule therapeutics targeting the Wiskott–Aldrich Syndrome protein for oncology and…
VRG TherapeuticsVRG Therapeutics designs therapeutic miniproteins using a proprietary platform that combines AI-driven protein engineering with wet-lab…
CytuvaxCytuvax develops cancer immunotherapy and vaccines for viral and bacterial pathogens, using depot-attached cytokines as immune-stimulating…